세계의 바이오칩 시장 : 마이크로어레이 및 랩온어칩

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

The biochip equipment and software market for biochip was valued at $6.8 billion in 2024 and is estimated to reach $11.6 billion by 2029, at a CAGR of 11.3% from 2024 through 2029.

The microfluidic biochips (lab-on-a-chip) market for biochip was valued at $2.5 billion in 2024 and is estimated to reach $4.6 billion by 2029, at a CAGR of 12.6% from 2024 through 2029.

Report Scope

This report provides an overview of the global biochip market and analyzes market trends. The report includes global revenue ($ million) for the base year 2023 and estimated data for the forecast period 2024 through 2029. The market is segmented based on product type, technology, application, end user industry and region. The regions covered in this study include North America, Europe, Asia-Pacific and Rest of the World (South America, the Middle East and Africa), focusing on major countries in these regions.

The report focuses on the significant trends and challenges that affect the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, which provides the ranking and shares of key companies in the global biochip market. There is also a dedicated section on company profiles that provides details about leading companies in the market.

The company profiles offer detailed information about business segments, financials, product portfolios and recent developments. By geographical region, the market has been segregated into North America, Europe, Asia-Pacific and the Rest of World, which includes the Middle East, Africa and South America. The North American region covers the U.S., Canada and Mexico. Europe examines Germany, the U.K., Italy, France, Spain and the Rest of Europe. Asia-Pacific encompasses China, Japan, India, Australia, South Korea and the Rest of Asia-Pacific. For market estimates, data has been provided for 2021 and 2022 as the historic years, 2023 as the base year, with estimates for 2024 and a forecast for 2025 through 2029.

Report Includes

• 76 data tables and 56 additional tables
• An analysis of the current and future global markets for biochip diagnostic products and technologies
• Analyses of global market trends, with historic revenue data from 2021 to 2024, and projected CAGRs through 2029
• Estimates of the size of and revenue prospects for the global biochip market, along with a market share analysis by product type, technology, application, end-user vertical, and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, and the impact of macro-economic factors
• A look at the major commercial biochip products and the future potential of each key market segment, emerging technologies, clinical trials, and other new developments
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading biotech companies
• Analysis of the industry structure, including companies' market shares, strategic alliances, M&A activity, venture fundings and investment outlook
• Company profiles of major players within the industry, including Abbott, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., and BioMerieux

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary

Chapter 2 Market Overview

• Overview and Market Definition
• Technology Background
• Technological Infrastructure and Data Integration

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Demand for Point-of-Care Diagnostics
• Increasing Investment and Funding in Biochip and Microarray Research Activities
• Increasing Prevalence of Cancer Generating Demand for Personalized Treatments
• Market Restraints and Challenges
• High Costs Associated with Developing and Implementing Biochip Technology
• Technical Challenges
• Market Opportunities
• Technological Advances and Automation in the Biochip industry
• Growing Volume of Clinical Research

Chapter 4 Regulatory Landscape

• Market Regulations by Agency
• The U.S.
• Federal Regulation
• CMS Regulation
• FDA Regulation
• FTC Regulation
• Canada
• European Union
• The U.K.
• China
• Japan
• Australia
• International Standards and Guidelines

Chapter 5 Emerging Technologies and Developments

• Artificial Intelligence in Biochip Technology for Biomedicine
• Advances in DNA and Protein Microarrays
• 3D Microarrays and Organoid-on-a-Chip
• Hydrogel-Based Microarrays
• Other Types of 3D Microarrays

Chapter 6 Market Segmentation Analysis

• Market Overview
• Segmentation Breakdown
• Global Biochip Market by Product
• Microarrays (Array-Based Biochips)
• Microfluidic Biochips (Lab-on-a-Chip)
• Biochip Equipment and Software
• Biochip Consumables and Kits
• Global Biochip Market by Technology
• Microarray Technology
• Microfluidics Technology
• Global Biochip Market by Application
• Genomics
• Proteomics
• Disease Diagnostics
• Drug Discovery and Development
• Global Biochip Market by End User
• Academic and Research Institutes
• Biopharmaceutical Companies
• Hospitals and Diagnostic Centers
• Geographic Breakdown
• Global Biochip Market by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of World (ROW)

Chapter 7 Competitive Intelligence

• Industry Structure
• Breakthrough Technologies and Product Launches
• Top Company Rankings
• Key Strategies Adopted by Companies
• Collaborations and Partnerships
• New Product Launch
• Expansion and Investment
• Mergers and Acquisitions

Chapter 8 Sustainability in the Biochip Market: An ESG Perspective

• Introduction to ESG
• ESG Performance in the Biochip Market
• ESG Practices in the Biochip Industry
• Environmental Performance
• Social Performance
• Governance Performance
• ESG Risk Ratings
• Concluding Remarks from BCC Research

Chapter 9 Appendix

• Methodology
• Abbreviations
• Company Profiles
• ABBOTT
• AGILENT TECHNOLOGIES INC.
• BIOMERIEUX
• BIO-RAD LABORATORIES INC.
• F. HOFFMANN-LA ROCHE LTD.
• IBIOCHIPS
• ILLUMINA INC.
• LI-COR BIOTECH LLC.
• MICRONIT B.V.
• NUTCRACKER THERAPEUTICS INC.
• QIAGEN
• RANDOX LABORATORIES LTD.
• REVVITY
• STANDARD BIOTOOLS
• THERMO FISHER SCIENTIFIC INC.